蛋白質合成研究綜述：2024

全球商業氨基酸市場規模預計將從 2024 年的 318 億美元成長到 2029 年的 428 億美元，預測期內的複合年成長率為 6.1%。

全球重組蛋白市場規模預計將從 2024 年的 1,418 億美元成長到 2029 年的 2,036 億美元，預測期內的複合年成長率為 7.5%。

全球聚乙二醇化蛋白質市場規模預計將從 2023 年的 102 億美元成長到 2028 年的 159 億美元，預測期間的複合年成長率為 9.4%。

蛋白質合成對於所有生物體都至關重要，它使細胞能夠產生生存和功能所需的蛋白質。這是在細胞內建構蛋白質的基本生物過程，對每個細胞功能都至關重要。蛋白質合成的主要成分是去氧核糖核酸（DNA）、核糖核酸（RNA）、核醣體和胺基酸。

由於慢性病的增加，對蛋白質療法的需求不斷增加，這是推動該市場發展的主要因素。無細胞系統的進步以及表現載體的改進提高了效率和生產力，也推動了蛋白質合成市場的發展。新興市場轉向無細胞系統、高通量技術以及個人化醫療的轉變也是蛋白質合成市場成長的主要因素。高昂的生產成本和複雜的技術正在影響市場的成長。

本研究評論包括 BCC Research 於 2024 年發布的有關商業氨基酸、重組蛋白、寡核苷酸、肽化蛋白和肽合成的報告的亮點和摘錄，並包括每個市場的全面概述、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展、市場規模趨勢和預測，以及各個細分市場和地區的詳細分析。

目錄

第 1 章 簡介

第 2 章 商業氨基酸（BIO007N）

• 市場展望
• 研究範圍
• 市場摘要
• 市場概況
• 商業利益
• 化學結構
• 市場動態
• 市場促進因素
• 市場限制
• 市場挑戰
• 市場機會
• 法律規範
• 全球法規結構
• 各類應用的監理要求
• 品管和製造標準
• 新興技術和發展
• 代謝工程與合成生物學
• 高通量篩檢與發酵最佳化
• 常規流動生物催化劑
• 先進的層析法技術
• 羥基氨基酸
• 綠色化學與永續生產
• 主要市場趨勢
• 商業胺基酸：世界市場
• 商業胺基酸市場（按產品類型）
• 甲硫胺酸
• 離胺酸
• 蘇胺酸
• 色氨酸
• 苯丙胺酸
• 麩胺酸
• 半胱胺酸
• 天門冬胺酸
• 甘胺酸
• 丙胺酸
• 精胺酸
• 脯胺酸
• 亮氨酸
• 巴林
• 酪胺酸
• 其他
• 商業胺基酸市場（按應用）
• 動物飼料
• 食品調味料
• 特殊用途
• 商業胺基酸市場（按地區）
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 世界其他地區
• 商業胺基酸的永續性：ESG 視角
• ESG：簡介
• 商業胺基酸市場的永續性
• 了解 ESG資料

3. 全球重組蛋白市場 (BIO254A)

• 市場展望
• 研究範圍
• 市場摘要
• 市場概況
• 表達宿主系統類型
• 重組蛋白的作用機制
• 重組蛋白生產的一般步驟
• 重組蛋白市場動態
• 驅動程式
• 限制因素
• 機會
• 重組蛋白的新技術與發展
• 蛋白質工程進展
• CRISPR基因組編輯
• 無細胞蛋白質合成
• 全球重組蛋白市場（依產品類型）
• 荷爾蒙
• 細胞激素
• 酵素
• 抗體
• 抗原
• 其他
• 全球重組蛋白市場（按宿主細胞類型）
• 細菌宿主細胞
• 酵母菌和真菌細胞
• 哺乳動物細胞
• 昆蟲細胞
• 其他
• 全球重組蛋白市場（按應用）
• 治療和疫苗
• 生物醫學研究
• 診斷
• 全球重組蛋白市場（按地區）
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 重組蛋白市場的永續性
• 了解 ESG資料
• ESG績效分析
• 結論

4. 寡核苷酸：世界市場（BIO220B）

• 市場展望
• 研究範圍
• 市場分析
• 市場概況
• 寡核苷酸合成的歷史
• 寡核苷酸類型
• 寡核苷酸合成的替代形式
• 合成寡核苷酸的多種功能
• 寡聚治療藥物的監管途徑
• 動物模型和研究
• 監理機構的作用
• 市場動態
• 市場促進因素
• 市場限制
• 市場機會
• 各領域新應用
• 寡核苷酸的新技術和發展
• DNA合成器
• 新興技術
• 全球寡核苷酸合成市場（按產品類型）
• 寡核苷酸藥物
• 設備和試劑
• 合成寡核苷酸
• 服務
• 全球寡核苷酸合成市場（按應用）
• 研究
• 診斷和治療
• 全球寡核苷酸合成市場（按地區）
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 寡核苷酸市場的 ESG 趨勢
• ESG：簡介
• 評估寡核苷酸製造流程的永續性
• 市場中的 ESG 表現
• 結論

5. 聚乙二醇化蛋白質市場 (BIO253A)

• 市場展望
• 研究範圍
• 市場摘要
• 市場概況
• 蛋白質聚乙二醇化的優勢
• 聚乙二醇化療法的局限性
• 聚乙二醇化蛋白質的市場動態
• 市場促進因素
• 市場限制
• 市場機會
• 新興技術和發展
• 非共用乙二醇化
• 奈米粒子的聚乙二醇化
• 抗體藥物複合體(ADC)
• 全球聚乙二醇化蛋白質市場（按蛋白質類型）
• 顆粒細胞增生因子（G-CSF）
• 聚乙二醇化單株抗體
• 聚乙二醇干擾素
• 聚乙二醇化重組因子
• 其他
• 全球聚乙二醇化蛋白質市場（依聚乙二醇化類型）
• 線性聚乙二醇化蛋白質
• 分支聚乙二醇化蛋白質
• 全球聚乙二醇化蛋白質市場（依聚乙二醇化應用）
• 自體免疫疾病
• 血液系統疾病
• 癌症
• 其他
• 全球聚乙二醇化蛋白質市場（按區域）
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 聚乙二醇化蛋白質市場的永續性：ESG 視角
• ESG：簡介
• 聚乙二醇化蛋白質產業的永續性
• 了解 ESG資料
• ESG績效分析
• 結論

6. 胜肽合成：世界市場（BIO252A）

• 市場展望
• 研究範圍
• 市場摘要
• 胜肽療法：市場概覽
• 胜肽的重要性
• 胜肽合成
• 肽療法的趨勢
• 市場動態
• 市場促進因素
• 市場限制
• 市場機會
• 胜肽合成和治療劑製造的新技術
• 水介質中 SPPS 的研究進展
• 化學合成
• 胜肽藥物輸送
• 新開發案例：按公司
• 細分市場分析
• 全球肽合成市場（按肽類型分類）
• 合成胜肽
• 抗菌胜肽
• 荷爾蒙胜肽
• 活性胜肽
• 膠原蛋白肽
• 其他
• 全球胜肽合成市場（按應用）
• 胜肽療法
• 化妝品
• 營養補充品
• 其他
• 全球胜肽合成市場（按合成類型）
• 固相
• 液相
• 混合
• 全球胜肽合成市場（按地區）
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 胜肽合成產業的永續性：ESG 視角
• ESG 對於胜肽治療藥物製造商的重要性
• 胜肽治療藥物製造商的 ESG 實踐
• BCC的觀點

第7章 附錄

The global market for commercial amino acids is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

The global market for recombinant proteins is expected to grow from $141.8 billion in 2024 to $203.6 billion by 2029, at a CAGR of 7.5% from 2024 through 2029.

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 to $15.9 billion by 2028, at a CAGR of 9.4% from 2023 through 2028.

Research Review Scope

Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), ribosomes, and amino acids.

The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments towards cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques affect the growth of the market.

The market includes major players such as Amgen Inc., Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of protein-synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO007N Commercial Amino Acids.
• BIO254A Global Recombinant Proteins Market.
• BIO220B Oligonucleotides: Global Markets.
• BIO253A PEGylated Proteins Market.
• BIO252A Peptide Synthesis: Global Markets.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Commercial Amino Acids (BIO007N)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Commercial Interests
• Chemical Structure
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Challenges
• Market Opportunity
• Regulatory Structure
• Global Regulatory Framework
• Regulatory Requirements for Different Applications
• Quality Control and Manufacturing Standards
• Emerging Technologies and Developments
• Metabolic Engineering and Synthetic Biology
• High-throughput Screening and Fermentation Optimization
• Continuous-Flow Biocatalysis
• Advanced Chromatography Techniques
• Hydroxy Amino Acids
• Green Chemistry and Sustainable Production
• Key Market Trends
• Commercial Amino Acids: Global Markets
• Commercial Amino Acids Market, by Product Type
• Methionine
• Lysine
• Threonine
• Tryptophan
• Phenylalanine
• Glutamic Acid
• Cysteine
• Aspartic Acid
• Glycine
• Alanine
• Arginine
• Proline
• Leucine
• Valine
• Tyrosine
• Other Amino Acids
• Commercial Amino Acids Market, by Application
• Animal Feed Applications
• Food Flavoring Applications
• Specialty Uses Applications
• Commercial Amino Acids Market, by Region
• North America
• Europe
• Asia-Pacific
• LATAM
• Rest of the World
• Sustainability in Commercial Amino Acids: An ESG Perspective
• Introduction to ESG
• Sustainability in the Commercial Amino Acids Market
• Understanding the ESG Data

Chapter 3 Global Recombinant Proteins Market (BIO254A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Types of Expression Host Systems
• Mechanism of Action of Recombinant Proteins
• Common Steps Involved in Recombinant Protein Production
• Market Dynamics of Recombinant Proteins
• Drivers
• Restraints
• Opportunities
• Emerging Technologies and Developments in Recombinant Proteins
• Protein-Engineering Advances
• CRISPR Genome Editing
• Cell-Free Protein Synthesis
• Global Market for Recombinant Proteins, by Product Type
• Hormones
• Cytokines
• Enzymes
• Antibodies
• Antigens
• Others
• Global Market for Recombinant Proteins, by Host Cell Type
• Bacterial Host Cells
• Yeast and Fungi Cells
• Mammalian Cells
• Insect Cells
• Other Cells
• Global Market for Recombinant Proteins, by Application
• Therapeutics and Vaccines
• Biomedical Research
• Diagnostics
• Global Market for Recombinant Proteins, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Recombinant Proteins Market
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 4 Oligonucleotides: Global Markets (BIO220B)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• History of Oligonucleotide Synthesis
• Types of Oligonucleotides
• Alternative Forms of Oligonucleotide Synthesis
• Versatile Functions of Synthetic Oligonucleotides
• Regulatory Paths for Oligotherapeutics
• Animal Models and Studies
• Role of Regulatory Authorities
• Global Market Dynamics for Oligonucleotides
• Market Drivers
• Market Restraints
• Opportunities in the Market
• Emerging Applications in Various Fields
• Emerging Technologies and Developments in Oligonucleotides
• DNA Synthesizers
• Emerging Technologies
• Global Market for Oligonucleotide Synthesis, by Product Type
• Oligonucleotide Drugs
• Equipment and Reagents
• Synthesized Oligos
• Services
• Global Market for Oligonucleotide Synthesis, by Application
• Research
• Diagnostics and Therapeutics
• Global Market for Oligonucleotide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Developments in the Oligonucleotide Market
• Introduction to ESG
• Assessing the Sustainability of the Oligonucleotide Manufacturing Process
• ESG Performance in Market
• Concluding Remarks

Chapter 5 PEGylated Proteins Market (BIO253A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Advantages of Protein PEGylation
• Limitations of PEGylated Therapeutics
• Market Dynamics for the PEGylated Proteins
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Non-Covalent PEGylation
• PEGylation of Nanoparticles
• Antibody-Drug Conjugates (ADCs)
• Global PEGylated Proteins Market, by Protein Type
• Granulocyte-Colony Stimulating Factors (G-CSF)
• PEGylated Monoclonal Antibodies
• PEGylated Interferons
• PEGylated Recombinant Factors
• Other Protein Types
• Global PEGylated Proteins Market, by PEGylation Type
• Linear PEGylated Proteins
• Branched PEGylated Proteins
• Global PEGylated Proteins Market, by PEGylation Application
• Autoimmune Diseases
• Hematology
• Cancer
• Other Applications
• Global PEGylated Proteins Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in PEGylated Proteins Market: ESG Perspective
• Introduction to ESG
• Sustainability in the PEGylated Proteins Industry
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 6 Peptide Synthesis: Global Markets (BIO252A)

• Market Outlook
• Scope of Report
• Market Summary
• Peptide Therapeutics Market Overview
• Importance of Peptides
• Peptide Synthesis
• Trends in Peptide Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraint
• Market Opportunities
• Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
• Advances in SPPS in Aqueous Media
• Chemical Synthesis
• Peptide Drug Delivery
• Examples of New Developments, by Company
• Market Analysis, by Segment
• Global Market for Peptide Synthesis, by Peptide Type
• Synthetic Peptides
• Antimicrobial Peptides
• Hormonal Peptides
• Bioactive Peptides
• Collagen Peptides
• Other Products
• Global Market for Peptide Synthesis, by Application
• Peptide Therapeutics
• Cosmetics
• Nutraceuticals
• Other Applications
• Global Market for Peptide Synthesis, by Synthesis Type
• Solid-phase
• Solution-phase
• Hybrid-phase
• Global Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Peptide Synthesis Industry: ESG Perspective
• Importance of ESG among Peptide Therapeutics Manufacturers
• ESG Practices of Peptide Therapeutics Manufacturers
• BCC Research Viewpoint

Chapter 7 Appendix

• Research Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 2 : Commercial Amino Acids, by Use
• Table 3 : Protein Amino Acids
• Table 4 : Applications of Selected Amino Acids
• Table 5 : Global Commercial Amino Acids Market, Through 2029
• Table 6 : Leading Global Producers of Amino Acids, by Product Type, 2023
• Table 7 : Global Commercial Amino Acids Market, by Product Type, Through 2029
• Table 8 : Methionine Content of Selected Foods
• Table 9 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 10 : Global Commercial Amino Acids Market, by Region, Through 2029
• Table 11 : North American Commercial Amino Acids Market, by Country, Through 2029
• Table 12 : European Commercial Amino Acids Market, by Country, Through 2029
• Table 13 : Asia-Pacific Commercial Amino Acids Market, by Country, Through 2029
• Table 14 : LATAM Commercial Amino Acids Market, by Country, Through 2029
• Table 15 : RoW Commercial Amino Acids Market, by Application, Through 2029
• Table 16 : ESG Rankings for Major Commercial Amino Acids Companies, 2024*
• Table 17 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 18 : Comparison of Different Protein Expression Host Systems
• Table 19 : R&D Expenditures of Key Biopharmaceutical Companies, 2023
• Table 20 : Global Market for Recombinant Proteins, by Product Type, Through 2029
• Table 21 : Global Market for Recombinant Proteins, by Host Cell Type, Through 2029
• Table 22 : Global Market for Recombinant Proteins, by Application, Through 2029
• Table 23 : Therapeutic Applications of Recombinant Proteins, by Product Type
• Table 24 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 25 : North American Market for Recombinant Proteins, by Country, Through 2029
• Table 26 : European Market for Recombinant Proteins, by Country, Through 2029
• Table 27 : Asia-Pacific Market for Recombinant Proteins, by Country, Through 2029
• Table 28 : ESG Rankings for Major Recombinant Protein Drug Companies, 2024*
• Table 29 : ESG: Environmental Overview
• Table 30 : ESG: Social Factors Overview
• Table 31 : ESG: Governance Overview
• Table 32 : Global Market for Oligonucleotides, by Region, Through 2028
• Table 33 : Comparison of Oligonucleotide and Polynucleotide
• Table 34 : List of Approved Oligonucleotide Therapeutics, 2023
• Table 35 : Global Market for Oligonucleotide Synthesis, by Product Type, Through 2028
• Table 36 : Revenue Generated, by Few Oligonucleotide Drugs, 2022
• Table 37 : Global Market for Oligonucleotide Synthesis, by Application, Through 2028
• Table 38 : Global Market for Oligonucleotide Synthesis, by Region, Through 2028
• Table 39 : North American Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 40 : European Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 41 : Asia-Pacific Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 42 : Assessment of the Oligonucleotide Manufacturing Process Against the 12 Principles of Green Chemistry
• Table 43 : Key Focus Areas in ESG Metrics
• Table 44 : ESG Rankings for Oligonucleotide Companies, 2023*
• Table 45 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 46 : PEGylated Drugs in Clinical Trials for Cancer
• Table 47 : Discontinued PEGylated Drugs in Clinical Trials
• Table 48 : Side Effects Observed with Approved Products
• Table 49 : Global Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 50 : Marketed PEGylated G-CSF Drugs
• Table 51 : Global Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 52 : Global Market for PEGylated Proteins, by Application, Through 2028
• Table 53 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 54 : North American Market for PEGylated Proteins, by Country, Through 2028
• Table 55 : North American Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 56 : North American Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 57 : North American Market for PEGylated Proteins, by Application, Through 2028
• Table 58 : European Market for PEGylated Proteins, by Country, Through 2028
• Table 59 : European Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 60 : European Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 61 : European Market for PEGylated Proteins, by Application, Through 2028
• Table 62 : Asia-Pacific Market for PEGylated Proteins, by Country, Through 2028
• Table 63 : Asia-Pacific Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 64 : Asia-Pacific Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 65 : Asia-Pacific Market for PEGylated Proteins, by Application, Through 2028
• Table 66 : RoW Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 67 : RoW Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 68 : RoW Market for PEGylated Proteins, by Application, Through 2028
• Table 69 : ESG Risk Rankings for Major PEGylated Protein Drug Companies, 2024*
• Table 70 : ESG: Environmental Overview
• Table 71 : ESG: Social Overview
• Table 72 : ESG: Governance Overview
• Table 73 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 74 : Pros and Cons of Liquid Phase and Solid Phase Synthesis
• Table 75 : Global Cancer Incidence, 2020
• Table 76 : Emerging Trends in Peptide Synthesis Technologies
• Table 77 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 78 : Global Market for Peptide Synthesis, by Application, Through 2028
• Table 79 : Peptide-based Drugs Approved by FDA in 2021
• Table 80 : Best-Selling Peptide Therapeutics, 1982-2021
• Table 81 : Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
• Table 82 : Global Market for Peptide Synthesis, by Region, Through 2028
• Table 83 : North American Market for Peptide Synthesis, by Country, Through 2028
• Table 84 : European Market for Peptide Synthesis, by Country, Through 2028
• Table 85 : Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
• Table 86 : RoW Market for Peptide Synthesis, by Country, Through 2028
• Table 87 : Role of ESG in Environmental Performance
• Table 88 : Role of ESG in Social Performance
• Table 89 : Role of ESG in Governance Performance
• Table 90 : ESG Rankings for Major Peptide Therapeutics Companies, 2023*

List of Figures

• Figure 1 : Snapshot of the Market Dynamics for Commercial Amino Acids
• Figure 2 : Global Commercial Amino Acids Market Share, by Product Type, 2023
• Figure 3 : Global Commercial Amino Acids Market Share, by Application, 2023
• Figure 4 : Global Commercial Amino Acids Market Share, by Region, 2023
• Figure 5 : North American Commercial Amino Acids Market Share, by Country, 2023
• Figure 6 : European Commercial Amino Acids Market Share, by Country, 2023
• Figure 7 : Asia-Pacific Commercial Amino Acids Market Share, by Country, 2023
• Figure 8 : LATAM Commercial Amino Acids Market Share, by Country, 2023
• Figure 9 : Global Market Shares of Recombinant Proteins, by Region, 2023
• Figure 10 : Basic Steps Involved in Recombinant Protein Production
• Figure 11 : Snapshot of the Market Dynamics of Recombinant Proteins
• Figure 12 : Global Biopharmaceutical R&D Expenditures, 2020-2026
• Figure 13 : Applications of Recombinant Antibodies
• Figure 14 : Advantages and Disadvantages of Continuous Manufacturing
• Figure 15 : Global Market Shares of Recombinant Proteins, by Product Type, 2023
• Figure 16 : Advantages of Recombinant Antibodies
• Figure 17 : Global Market Shares of Recombinant Proteins, by Host Cell Type, 2023
• Figure 18 : Global Market Shares of Recombinant Proteins, by Application, 2023
• Figure 19 : North American Market Shares of Recombinant Proteins, by Country, 2023
• Figure 20 : European Market Shares of Recombinant Proteins, by Country, 2023
• Figure 21 : Asia-Pacific Market Shares of Recombinant Proteins, by Country, 2023
• Figure 22 : Key ESG Metrics of Recombinant Protein Companies
• Figure 23 : Global Market Shares of Oligonucleotides, by Region, 2022
• Figure 24 : Classification of Synthetic Oligonucleotides
• Figure 25 : Dynamics of the Global Market for Oligonucleotides
• Figure 26 : Global Market Shares of Oligonucleotide Synthesis, by Product Type, 2022
• Figure 27 : Global Market Shares of Oligonucleotide Synthesis, by Application, 2022
• Figure 28 : North American Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 29 : European Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 30 : Asia-Pacific Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 31 : How a Strong ESG Proposition Benefits Businesses
• Figure 32 : ESG Adoption Level across Industries, 2021 and 2022
• Figure 33 : Advantages of Protein PEGylation
• Figure 34 : Timeline of PEGylated Protein Therapeutics
• Figure 35 : Disadvantages of PEGylated Protein Therapeutics
• Figure 36 : Market Dynamics of Global PEGylated Proteins
• Figure 37 : Emerging Technologies in the PEGylated Proteins Market
• Figure 38 : Global Market Shares of PEGylated Proteins, by Protein Type, 2022
• Figure 39 : Global Market Shares of PEGylated Proteins, by PEGylation Type, 2022
• Figure 40 : Global Market Shares of PEGylated Proteins, by Application, 2022
• Figure 41 : Global Market Shares of PEGylated Proteins, by Region, 2022
• Figure 42 : North American Market Shares of PEGylated Proteins, by Country, 2022
• Figure 43 : European Market Shares of PEGylated Proteins, by Country, 2022
• Figure 44 : Asia-Pacific Market Shares of PEGylated Proteins, by Country, 2022
• Figure 45 : Snapshot of ESG Pillars
• Figure 46 : Advantages of ESG for Companies
• Figure 47 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 48 : Trends in Peptide Therapeutics Manufacturing
• Figure 49 : Snapshot of the Market Dynamics for Peptide Synthesis
• Figure 50 : India's Biotechnology Sectoral Thrust
• Figure 51 : Global Projected Incidence of Diabetes, Patients Aged 20-79 Years, 2010 and 2030
• Figure 52 : Global Infectious Disease Outbreaks, 2020 to 2022
• Figure 53 : Global Infectious Disease Outbreak, 2022
• Figure 54 : Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
• Figure 55 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 56 : Global Market Shares of Peptide Synthesis, by Application, 2022
• Figure 57 : Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 58 : Global Market Shares of Peptide Synthesis, by Region, 2022
• Figure 59 : North American Market Shares of Peptide Synthesis, by Application, 2022
• Figure 60 : North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 61 : North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 62 : North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 63 : North American Market Shares of Peptide Synthesis, by Country, 2022
• Figure 64 : European Market Shares of Peptide Synthesis, by Application, 2022
• Figure 65 : European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 66 : European Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 67 : European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 68 : European Market Shares of Peptide Synthesis, by Country, 2022
• Figure 69 : Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
• Figure 70 : Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 71 : Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 72 : Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 73 : Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
• Figure 74 : RoW Market Shares of Peptide Synthesis, by Application, 2022
• Figure 75 : RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 76 : RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 77 : RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 78 : RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
• Figure 79 : Snapshot: Key ESG Trends in Peptide Therapeutics Industry